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Summary  
This study sought to assess the relative levels of the mRNAs of the core proteins of the small proteoglycans (PGs) 
biglycan, decorin and fibromodulin in the hypertrophic phase of the early osteoarthritis (OA) that follows joint injury. 
Experimental OA was induced in eight dogs by transection of the anterior cruciate ligament. Articular cartilage was 
harvested from each joint, the total RNA was extracted and the concentration of DNA in the cartilage was measured. 
The relative levels of mRNA for biglycan, decorin and fibromodulin were assessed by northern blot analyses. An increase 
in cartilage mass with no increase in DNA concentration confirmed that the joints were in the hypertrophic phase that 
follows joint injury. The total RNA per microgram of DNA was increased 2.5 times. Compared with control cartilage, 
the mRNA levels in osteoarthritic cartilage, when normalized to the concentration of DNA, were increased 3.9 times 
for biglycan, 1.2 times for decorin and 2.4 times for fibromodulin. Because these small PGs affect collagen fibrillogenesis 
in vitro, their discoordinate metabolism ay contribute to the abnormal collagen formation and deposition that occurs 
in OA and to the ultimate failure of the articular cartilage. 
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I n t roduct ion  
IN ARTICULAR CARTILAGE there are at least four 
dist inct  extracel lu lar  matr ix  proteoglycans 
(PGs): aggrecan, biglycan, decor in and fibro- 
modul in.  Aggrecan monomers bind specif ically 
with hya luronan forming enormous, hydrophi l ic  
macromolecu lar  complexes, which make a major  
contr ibut ion to the viscoelast ic propert ies of 
ar t icu lar  carti lage. In contrast ,  biglycan, decor in 
and f ibromodul in are much smal ler (each approxi- 
mately 50 kDa compared with more than  600 kDa 
for aggrecan) and have only one or two glycos- 
aminoglycan (GAG) chains compared with more 
than  80GAG chains usual ly at tached to the 
aggrecan core protein. In carti lage, the small  PGs 
represent  1-2% of the tota l  mass of the PGs, but 
because of thei r  smal ler  size they may normal ly  be 
present  in molar  concentrat ions  similar to that  of 
aggrecan [1]. 
Biglycan, decor in and f ibromodul in share sub- 
stant ia l  nucleic acid and amino acid sequence 
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homology: a domain consist ing of 10 repeats  of a 
leucine-r ich mot i f  [2-5] comprises the major i ty  of 
thei r  respective core proteins. When present  in 
other  proteins, such domains inf luence protein- 
prote in interact ions  [6, 7]. Despite their  extensive 
homology, these small  proteoglycans appear  to 
interact  with the major  cart i lage matr ix  protein,  
type II collagen, by dist inct ly different mechan-  
isms. The core proteins of both decor in  and 
f ibromodul in bind type II col lagen in vitro slowing 
the rate of f ibri l logenesis [8, 9]. Curiously, decor in  
and f ibromodul in bind at different sites on the 
col lagen fibril [10], suggesting these small  proteo- 
glycans may inf luence col lagen f ibri l logenesis 
in concert .  Unl ike decor in  and f ibromodul in,  
biglycan binds to type II and other  col lagens under  
somewhat different in vitro assay condit ions (i.e., 
only at more physiological  phosphate concen- 
trat ions) and binds dif ferently (i.e., th rough its 
GAG chains [11]). Biglycan also competes with 
decor in and type II col lagen for b inding to the 
globular domain of immobil ized type VI Collagen 
in vitro [12]. A l though the in vivo funct ion of  
the small PGs is poor ly understood,  di f ferences 
in their  d istr ibut ion with in art icu lar  cart i lage 
suggest hat  they may have dist inct funct ions in the 
tissue. Both decor in and f ibromodul in are present  
in h igher  concentrat ions in the superf icial  zone of  
normal  adul t  ar t icu lar  cart i lage [13, 14], where the 
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collagen fibrils are thin [15]. Decorin is localized 
throughout he interterritorial and pericellular 
matrix of the superficial zone, whereas fibromod- 
ulin appears confined to the interterritorial matrix 
[13]. Biglycan is found predominantly in the 
pericellular matrix and is enriched in proliferating 
cartilage [16]. These differences in their localiz- 
ations suggest a compartmentalized function 
involving assembly, transport and incorporation of 
collagen in the extracellular matrix. 
Compared with aggrecan, relatively little is 
known about the metabolism of the small PGs in 
osteoarthritis (OA), particularly in early OA. The 
overall content of decorin and biglycan reportedly 
stays nearly the same in endstage osteoarthrit ic 
human cartilage compared with normal age- 
matched cartilage, but their spatial distribution 
changes markedly [17]. In another study, fibrillated 
osteoarthritic human cartilage reportedly has a 
higher concentration of dermatan sulfate PGs 
(DSPGs) (decorin and/or biglycan) than normal 
cartilage, and these DSPGs reportedly are stronger 
inhibitors of type II collagen fibrillogenesis in vitro 
than DSPGs from normal cartilage [18]. Further- 
more, chondrocytes isolated from osteoarthrit ic 
human cartilage secrete significantly more small 
PGs into the culture medium than do those isolated 
from normal cartilage [19]. Similarly, in the early 
stages of canine experimental OA, osteoarthrit ic 
cartilage explant cultures reportedly synthesized 
greater amounts of the DSPGs than controls and 
this increase in synthesis was potentiated by 
transforming rowth factor-fl (TGF-fl) [20]. 
OA, in its late stages, is characterized by 
progressive thinning of the articular cartilage, 
when, presumably, degradation exceeds ynthesis. 
However, in animal models of early OA and 
in cartilage cultured from human osteoarthrit ic 
cartilage, themRNA levels and the rates of 
biosynthesis of both aggrecan [21-26] and type II 
collagen [26-29] are increased. That the rate of 
protein biosynthesis [21, 27] is similar to the 
increase in the relative levels of mRNA [26] 
suggests that regulation of synthesis occurs 
predominantly at the level of transcription. This 
results in thickened and hypertrophic cartilage 
[22, 24-26, 30, 31]. Yet in the early, anabolic phase 
of OA, as assessed with an animal model, it is 
aggrecan, not collagen, that accumulates in the 
hypertrophic articular cartilage [22, 30]. Increased 
levels of the C-propeptide of the secreted type II 
collagen localize in the pericellular matrix of 
osteoarthritic artilage [32] which suggests that 
type II collagen is translated and secreted. Failure 
to accumulate type II collagen suggests an 
impairment of transport, assembly and incorpor- 
ation of the mature type II collagen protein into the 
matrix. Because the small PGs can affect collagen 
assembly in vitro (and possibly its transport and 
incorporation into the matrix in vivo), we postulate 
that changes in their metabolism ay contribute to 
the abnormal collagen metabolism in OA. To assess 
this hypothesis, we have measured the mRNA 
levels for the small PGs in the hypertrophic phase 
of experimental OA. 
Mater ia l s  and  Methods  
ANIMALS 
Eight skeletally mature, mixed-breed, male dogs 
(30-35 kg) were used. Five of the dogs were also 
used in a previous tudy [26]. They were housed in 
kennels [2.5 x I x 2 m(1 x w × h)], fed laboratory dog 
chow (United Feeds, Olds, AB, Canada), were given 
access to tap water ad libitum and were cared 
for under the supervision of a veterinarian. The 
anterior (cranial) cruciate ligament (ACL) of 
one knee (stifle) of each animal was transected 
surgically using a lateral arthrotomy as described 
previously [33]; the contralateral kneeserved  
as the non-operated control. Two milliliters of 
penicillin (Penlong TM XL, Rogar/STB Inc., Mon- 
treal, PQ, Canada) was administered intramuscu- 
larly following surgery; the topical antiseptic 
gentamicin (Gentocin TM, Schering Canada Inc., 
Pointe-Claire, PQ, Canada) was sprayed on the 
surgical wound site daily until the skin sutures 
were removed at 7 days after surgery. Animals were 
killed 10 weeks after surgery by an overdose 
of intravenous barbiturate (Euthanyl TM, M.T.C. 
Pharmaceuticals, Cambridge, ON, Canada). 
HARVESTING OF ARTICULAR CARTILAGE AND 
ISOLATION OF TOTAL RNA 
Articular cartilage was shaved from the entire 
articular surface of the femoral condyles, patella 
and tibial plateaus of each knee using a sterile 
scalpel, with care taken to avoid marginal tissue 
and osteophytic artilage. Cartilage shavings were 
placed immediately into liquid nitrogen in sterile, 
pre-weighed 50ml polypropylene tubes. Excess 
liquid nitrogen was poured off and allowed to 
evaporate just before weighing the tubes to attain 
the frozen tissue mass of the cartilage. This was 
then stored at -70°C. One gram of the frozen 
shavings were subsequently placed in a Spex TM 
Freezer Mill (Model 6700, Edison, NJ, U.S.A.), 
which had been pre-cooled with liquid nitrogen, 
and were pulverized into a coarse powder by 
processing at maximum agitation for 1 min [34]. 
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A 5 mg sample of pooled cartilage powder was 
taken from each joint to measure the concentration 
of DNA for each joint using a fluorophotometric 
technique with the Hoechst 33258 dye (Sigma 
Chemical Co., St. Louis, MO, U.S.A.) [35]. Serial 
dilutions of calf thymus DNA (Sigma Chemical Co., 
St. Louis, MO, U.S.A.) were used as standards. 
The amount of DNA in the articular cartilage 
samples was calculated from the linear regression 
equation determined from the standards. RNA was 
extracted from the remaining cartilage powder, as 
described previously [26, 34]. 
NORTHERN HYBRID IZAT ION 
Five micrograms of purified total RNA was 
stained with ethidium bromide and run on a 0.8% 
agarose formaldehyde gel. The gel was photog- 
raphed using fluorescent transil lumination using a 
Polaroid MP-4 Land Camera and type 55 film 
(Polaroid, Cambridge, MA, U.S.A.). The RNA was 
then transferred by capillary action from the gel to 
nylon membranes (ICN Bio Trans, 0.2 pm pore size) 
and immobilized by ultraviolet radiation (120 
000 microjoules/cm2; Stratagene Stratalinker 1200, 
La Jolla, CA, U.S.A.). 
Three different probes were used to assess mall 
proteoglycan mRNA levels: (1) a 1600 base pair (bp) 
cDNA clone corresponding to human decorin (36), 
(b) a 1685 bp cDNA clone corresponding to human 
biglycan (36) (GenBank TM accession umber J04599) 
and (3) a 2660 bp cDNA clone corresponding to the 
complete coding sequence for bovine fibromodulin 
[4] (GenBank TM accession number X16485). The 
cDNA clones for biglycan and decorin were ligated 
into the pBluescript SK vector, cRNA probes were 
synthesized f romthese  recombinant vectors by 
in vitro transcription according to the manu- 
facturer's instructions (Stratagene RNA Transcrip- 
tion Kit 200340, La Jolla, CA, U.S.A.) using the 
T7 promoter, DNA polymerase and [32p]-UTP 
(DuPont NEG-007C, Boston, MA, U.S.A.) as the 
radiolabel. The cDNA for bovine fibromodulin was 
released from the pUC9 derivation vector, pUCX1 
using the restriction enzyme EcoR1, run through 
a 1% agarose gel containing I×TAE buffer 
[37] and purified with the GeneClean TM Kit 
(Biol01, La Jolla, CA, U.S.A.). The purified cDNA 
clone was then radiolabeled using the Random 
Primers Labeling Kit (BRL, Bethesda, MA, U.S.A.) 
according to the manufacturer's instructions 
and [~2P]-dATP (Amersham PB. 10204, Arlington 
Heights, I1, U.S.A.) as the radiolabel. All probes were 
radiolabeled to a specific activity of approximately 
109 cpm/#g. Each probe was hybridized separately at 
temperatures between 45-55°C and washed at the 
same hybridization temperatures athigh stringency 
in 0.1 × SSC buffer [37]. Following hybridization and 
detection of signals by contact film autoradiography 
(described below), the probes were removed from the 
membranes by boiling in 0.1 × SSC buffer for 15 min. 
Because these were not canine probes, their 
specificity for canine mRNA was checked in 
preliminary studies. All were found to hybridize 
specifically with high stringency at the same sites as 
in other species, including the double band of 
decorin that results from alternative polyadenyla- 
tion [38]. 
Specific hybridization signals were detected 
by contact film autoradiography using Kodak XAR5 
film without intensifying screens. Autoradiograms 
were processed in Kodak GBX developer and fixer 
solutions. The relative integrated optical density of 
the autoradiographic signals and the 18 S rRNA 
ethidium bromide fluorescence signals (from Polar- 
oid type 55 photographic negatives) were quantified 
by two-dimensional laser scanning densitometry 
(Scanalytics, Billerica, MA, U.S.A.) 
STAT IST ICAL  ANALYSES 
Osteoarthritic and contralateral control samples 
were compared by paired sample t-tests with 
statistical significance determined at an alpha 
value of 0.05. The osteoarthrit ic values were plotted 
vs those of the controls and the location of the 
points were compared relative to the line of identity. 
Thus, each point represents a paired sample from a 
single animal. The line of identity (slope = 1.0) 
represents values that would be expected if there 
were no change between the osteoarthritic and 
control values. For each of the probes, least-squares 
linear regression coefficients were determined. The 
regression coefficient expresses what change in 
osteoarthrit ic samples is associated, on average, 
with a unit change in control samples [39]. 
Resu l ts  
MACROSCOPIC  EXAMINAT ION 
No obvious cartilage lesions were observed at the 
time of surgery and no post-operative complications 
of surgery were observed. At necropsy, no 
macroscopic evidence of arthritis was observed 
in the hips, ankles, or contralateral knees. In all the 
non-operated knees the ACL was intact, the 
articular cartilage was shiny and translucent-blue; 
only a small volume (<0.2 ml) of synovial fluid was 
present. In contrast, in all the operated knees, 
the articular cartilage was dull and opaque-white, 
numerous marginal osteophytes were seen, the 
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ACL stumps were b lunt  and degenerated and 
there was a copious volume (>4ml )  of synovial  
fluid. 
osteoarthr i t ic  cart i lage was increased by 1.6 times 
compared with the control  carti lage. 
CARTILAGE MASS 
The mass of art icu lar  cart i lage for the eight pairs 
of joints is plotted in Fig. 1. In this X -Y  scatterplot,  
all the data points lie above the line of ident i ty 
(slope = 1.0), indicat ing that  the mass of art icu lar  
cart i lage was greater in operated knees than  in 
the contralateral  non-operated knees. This differ- 
ence was statist ical ly signif icant (P=0.00042), 
suggesting that  these dogs were in the hyper- 
trophic phase of this experimental  OA. L inear  
regression analysis indicated that  the mass of the 
AMOUNTS AND CONCENTRATIONS OF DNA AND RNA 
The tota] amount of DNA per joint is plotted in 
Fig. l(b). These data points straddle the line of 
identity and the values for the osteoarthritic 
cartilage did not differ from those in the control 
cartilage (P = 0..09). The concentration fDNA per 
gram of articular cartilage is plotted in Fig. 1(c). 
All the points lie below the line of identity; the 
concentration of DNA was 0.7 times less in the 
osteoarthritic artilage samples compared with 
their controls (P = 0.049). 
The total amount of RNA per joint is plotted 
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FIG. 1. Relative change in the articular cartilage mass and nuclei acid amounts and concentrations. (a)Relative change 
in the articular cartilage mass. The mass of (frozen) articular cartilage is plotted for eight pairs of knees. For all graphs, 
the values for osteoarthritic joints are plotted on the ordinate and the values for the non-operated contralateral control 
joints are plotted on the abscissa. The line of indentity (slope = 1.0) is dashed and indicates where osteoarthritic and 
control joints would be equal. When a point falls above the line of indentity, the value for the osteoarthritic joint 
exceeds the corresponding control joint; when it falls below, the reverse is true. The osteoarthritic samples have 
significantly greater cartilage mass then their corresponding contralateral controls (P = 0.00042), (b) Total DNA per 
joint. The total amount of DNA (#g) per joint is plotted for the eight pairs of knees. These points straddle the line 
of identity; there is no significant difference between osteoarthritic and control samples (P = 0.092). (c) Concentration 
of DNA per gram of articular cartilage. The concentration ofDNA (micrograms DNA per gram cartilage) for the eight 
pairs of joints. These points fall below the line of identity; the values for osteoarthritis are significantly less than the 
controls (P = 0.049). (d) Total RNA per joint. The total amount of RNA (pg) extracted from the cartilage for the eight 
pairs of joints. The osteoarthritic joints have significantly more RNA than controls (P = 0.00011). (e) Concentration of
RNAper gram of articular cartilage. The concentration f RNA (microgram RNA per gram cartilage) for the eight pairs 
of joints. The values for the osteroarthritic samples are significantly greater than their corresponding controls 
(P--0.0002). (f) Concentration of total RNA per #g DNA. The concentration of RNA normalized to the concentration 
of DNA (i.e., microgram of RNA per gram cartilage per microgram of DNA per gram cartilage) for the eight pairs of 
joints. The RNA/DNA ratio of the osteoarthritic samples is significantly higher than controls (P=0.00037). 
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FIG. 2. Northern blots of decorin, biglycan and fibromodulin. Top panel: Ethidium bromide staining patterns of total 
RNA in an agarose gel (5/tg per lane). Bottom three panels: Autoradiographic hybridization signals of biglycan, decorin 
and fibromodulin core protein probes. Eight pairs of joints (C = control; E = experimental osteoarthritis). The 16 lanes 
from left to right are total RNA extracted from paired joints of dogs: I-VIII (C = control and E = experimental). 
in Fig. l(d) and the amount of RNA per gram of 
articular cartilage is plotted in Fig. l(e). The con- 
centration of RNA normalized to the concentration 
of DNA is plotted in Fig. l(f). In Fig l(e) and (f), all 
data points lie above the line of identity, indicating 
that, compared to control cartilage, osteoarthritic 
cartilage was enriched by 2.2 times in total RNA per 
gram of cartilage (P=0.0002) and by 2.5 times in 
total RNA per microgram of DNA (P= 0.00037). 
NORTHERN BLOTS 
The fluorescence of ethidium bromide-stained 
RNA and the relative autoradiographic signals for 
decorin, biglycan and fibromodulin are shown in 
Fig. 2. To assess the RNA loading, the optical 
dengities of the 18 S RNA bands in the experimen- 
tal and control lanes were compared (Table I). 
A t-test of paired sample means revealed that 
the amount of 18 S rRNA was different in the 
osteoarthritic lanes as compared with those of 
the controls. In four of the dogs (I, II, V, VII), the 
increase in the osteoarthritic lane was greater 
by a factor of 5% or more, as compared with the 
corresponding control lane. In these cases, 
the corresponding total RNA concentration were 
corrected so that they were comparable. Thus, 
the reported mRNA levels have been corrected 
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-,1P 
for these var iat ions in loading under  the assure- 
priori that  a proport ionate amount  of mRNA was 
~nisloaded. The biglycan probe hybridized at 
approximately 2.6 kbp; the decor in probe hybr idized 
at the two character ist ic  1.6 and 1.9 kbp posit ions 
(two bands because of a l ternate polyadenylat ion 
sites) [38]; and the f ibromodul in probe hybridized at 
approximately 2.7 kbp. These posit ions are similar 
to nor thern  blot hybridizat ions for these probes 
with other species [3, 4, 36]. The relative autoradio- 
graphic intensit ies of the films shown in Fig. 2 are 
plotted in Fig. 3(a). The signals for decor in and 
f ibromodulin were lower in osteoarthr i t ic  carti lage, 
whereas the biglycan signal was higher in 
osteoarthr i t ic  art i lage than  in controls. When 
expressed per 5 pgRNA, the difference between 
osteoarthr i t ic  and contro l  cart i lages is signif icant 
for the biglycan (P=0.027) and for decor in 
(P=0.011) but not for f ibromodul in (P=0.327). 
Fig. 3(b) shows the plot of the relative change in 
autoradiographic signals when normal ized to the 
concentrat ion of DNA. As indicated by the 
regression coefficients in Fig. 3(b), the average 
signal is increased 3.9 t imes for biglycan, 1.2 t imes 
for decorin and 2.4 t imes for f ibromodul in in 
osteoarthr i t ic  art i lage compared with controls. 
These differences are all statist ical ly signif icant 
(biglycan: P = 0.002, decorin: P = 0.042 and fibromod- 
ulin: P = 0.003). 
Discussion 
The small PGs biglycan, decor in and f ibromodulin 
are essential components of ar t icu lar  cart i lage that 
are presumably involved in the assembly and 
maintenance of the extracel lu lar  matrix. In this 
study the relative levels of the mRNAs for the core 
proteins of these PGs were increased in the 
Table I 
The integrated o.d. units (normalized per 5 pg RNA) of 
the ethidium bromide stained 18 S rRNA from the total 
RNA from the osteoarthritic and control knees for each 
dog 
Integrated o.d. units of the ethidium bromide 
stained 18 S RNA 
Dog Control Osteoarthritis 
I 20.45 23.50 
II 15.13 21.09 
III 13.13 13.18 
IV 29.63 30.34 
V 15.98 20.29 
VI 9.65 9.61 
VII 13.97 19.78 
VIII 21.87 21.97 
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FIG. 3. Densitometric analyses of the northern blots of 
decorin, biglycan and fibromodulin. (a) Densitometric 
analysis based on the loaded amounts (5#g RNA). 
Densitometry of autoradiograms in the bottom three 
panels of Fig. 2 (based on 5 #g RNA). Absorbance (in 
relative absorbance units) of the eight pairs of OA and 
control joints. The line plotted for each probe is the least 
squares linear regression line with the control samples 
as the independent variable and the osteoarthritie 
samples as the dependent variable. The difference 
between osteoarthritic and control joints is significant 
for biglyean (P = 0.027) and for deeorin (P = 0.011) but not 
for fibromodulin (P=0.327). (b) Densitometrie analysis 
normalized to DNA concentration because the osteoar- 
thritis cartilage is enriched 2.5 times in total RNA 
relative to DNA [see Fig. l(e)], the values plotted in 
Fig. 3(b) are replotted after normalization to DNA. The 
lines are the least squares regression lines. When 
analyzed this way, in osteoarthritic cartilage as 
compared with controls, the average signal for biglycan 
is increased 3.9 times (P = 0.002), decorin is increased 1.2 
times (P= 0.042) and fibromodulin is increased 2.4 times 
(P = 0.003). 
osteoarthr i t ic  cart i lage compared with the control  
carti lage. The observat ion that the overall synthesis 
of small PGs is a l tered in cart i lage cu l tured from 
this exper imental  OA [20] corroborates our  findings. 
A l though these small PGs have extensive sequence 
homologies [2, 4, 36], their  mRNA levels were not 
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altered proportionately in the osteoarthritic carti- 
lage. Because of their putative role in collagen 
assembly in the matrix, this discoordinate gene 
expression may indirectly lead to altered assembly 
of the collagen network, giving rise to impaired 
mechanical function and the ultimate failure of the 
osteoarthritic cartilage. 
These experiments depend upon several assump- 
tions. First, the non-operated contralateral stifle 
joint was used as an internal control. It is plausible 
that the increased gene expression of the small 
PGs observed in the osteoarthritic joint could 
be explained by a decrease with respect to the 
non-operated contralateral joint. However, because 
the articular cartilage mass and PG metabolism are 
similar between normal joints from non-operated 
animals and non-operated contralateral joints 
[30], and because there does not appear to be 
compensatory overloading of the contralateral 
stifle following cartilage injury [40], the changes 
observed in this study most likely reflect a real 
increase in gene expression. Second, while the 
relative levels of mRNA do not necessarily reflect 
the amount of protein synthesized, there is 
circumstantial evidence from other studies [21, 26] 
that the mRNA is translated into protein. However, 
to define the stoichiometry of this in vivo would 
require in vivo labeling studies which would be 
extremely difficult, if not impossible, to perform. 
There was variability among individual dogs in 
this study. Some biochemical studies using this 
animal model have also found individual variabili- 
ties [33]. Whereas some factors in this study, 
including age, sex, weight, type of diet, surgical 
technique and time between being killed and 
surgery, were relatively easy to keep constant, 
some variables were more difficult to control. 
The dogs were allowed food, water and exercise 
ad l ibitum. The dogs were not isogenic, but were 
from the same kennel and were cross-bred with 
the same general lineage. It is not surprising, then, 
that there was variability between the dogs. 
However, these variables were not the central focus 
of this study. With respect o the variability, there 
was no correlation between dog weight, increase 
in cartilage mass or any of the changes in the 
expression of the small PGs. In spite of the 
variability, statistically significant differences 
were found. Given that the aim of the study was 
to quantify the change in the relative levels of 
mRNA for the small PG core proteins in 
osteoarthritic cartilage, the approach of analyzing 
the mean values and regression, as opposed to 
individual values for the various criteria, allowed 
comparisons between osteoarthritic and control 
cartilages using paired sample t-tests. 
An advantage of this study is that the relative 
changes in the small PG core proteins could 
be compared on the same sample of cartilage 
RNA. Although the relative increases in gene 
expression for the small PGs at this timepoint in 
experimental OA may not reflect their levels 
throughout the disease process, characterization f 
mRNA levels in other stages of experimental OA is 
underway. 
Consistent with a previous study [26], the 
present study demonstrates that the anabolic 
activation of osteoarthritic hondrocytes, as as- 
sessed by an increase in total RNA, without a net 
change in DNA concentration (an index of cell 
number) and is characteristic of the hypertrophic 
phase of articular cartilage that follows joint 
injury in this experimental OA. Although the total 
amount of DNA in the articular cartilage did 
not change when evaluated per joint, because 
the cartilage mass increased, the concentration 
of DNA decreased significantly. However, the 
chondrocytes are metabolically more active, as 
evidenced by an increase of 2.5 times in the total 
RNA ~ per microgram DNA in the cartilage from 
the operated side compared with the control. 
These findings define this as the hypertrophic 
phase of early OA (cartilage hypertrophy without 
chondrocyte hyperplasia) [41]. It may seem surpris- 
ing that the amount of DNA per joint decreases, 
because cloning of chondrocytes occurs in OA, 
and has been demonstrated in this model in the 
early stages, not just in late stage OA [42]. However, 
necrosis of the chondrocytes, especially of the 
superficial femoral condyles has also been reported 
in this model [43]. Furthermore, Bcl-2 has recently 
been demonstrated in normal and osteoarthrit ic 
human cartilage, with an increased amount 
present near osteoarthritic defects in the cartilage, 
suggesting apoptosis may occur in OA. Thus there 
is evidence of both cell division and cell loss. 
No assessment of the details of the changes in 
cell density in osteoarthritic artilage using 
more recent unbiased measures [44, 45] has been 
performed. 
Because the mass of cartilage and the concen- 
tration of RNA increase in osteoarthritic cartilage 
whereas the total amount of DNA remains nearly 
constant, it seems most meaningful to normalize 
the signal of a particular mRNA to the concen- 
tration of DNA. When normalized, the mRNA 
levels of the three small PGs all were elevated 
significantly in osteoarthritic cartilage. 
Previous work has shown that in the hyper- 
trophic phase of the early OA occurring after 
transection of the ACL in dogs [20-22] the 
concentration of aggrecan is increased in the 
194 Dourado et al.: Small PGs in experimental OA 
cartilage of the operated knee but the concen- 
tration of collagen is decreased [22]. This deft- 
ciency of collagen 
results, at least in 
increased activities 
and other proteases 
synovium in both 
established human 
early osteoarthritic 
in the matrix undoubtedly 
part, from the demonstrated 
of stromelysin, collagenase 
in both the cartilage and the 
early experimental OA and 
OA [46-51]. In addition, in 
artilage the level of tissue 
inhibitor of matrix metalloproteinase (TIMP) is 
not increased in proportion to the increase in the 
activity of the matrix metalloproteinases, and this 
probably contributes to the degradation of collagen 
[46, 49]. The unwinding of native type II collagen 
in the superficial and mid-zones in the peri- 
cellular matrix of osteoarthrit ic cartilage [52] also 
provides evidence for the enzymatic disruption of 
the fibrillar network. However, other factors may 
contribute to the abnormal collagen metabolism in 
OA. First, collagen anabolism is increased greater 
than that of aggrecan whereas tromelysin activity 
is greater than that of collagenase. The mRNA level 
[26] and rate of synthesis [27, 28, 52] of type II 
collagen in vivo is each increased by eight to 10 
times, but the mRNA level [26] and rate of synthesis 
[21] of aggrecan is each increased only ~ 2 times 
in vivo. However, in cartilage from endstage human 
OA [53] and from experimentally induced OA 
in rabbits [54], the levels of mRNA for stromelysin 
are significantly higher than those for collagenase. 
Furthermore, although the total amount of 
collagen changes little or even decreases in the 
cartilage in this experimental OA [22], the collagen 
fibers have a smaller diameter [15, 55] and new 
fine diameter, abnormal fibers appear [56,57]. 
The abnormal levels of small PGs in osteoarthritic 
cartilage may contribute to these changes in 
collagen metabolism. 
The observed increase in biglycan and decorin 
mRNA is reminiscent of the action of TGF-fl on 
cartilage or fibroblasts in vitro [20, 58-60]. In only 
one study was fibromodulin assessed and no effect 
of TGF-fl on its synthesis and secretion was noted 
[58]. Furthermore, in an animal model of pulmon- 
ary fibrosis, an increase in the mRNA for TGF-fl 
was followed by an increase in the biglycan mRNA, 
a decrease in the decorin mRNA and no change 
in the fibromodulin mRNA [61]. These results 
are similar to the results of the present study 
before the data was normalized to the concen- 
tration of DNA. It is notable that high concen- 
trations of TGF-fl (about 300 ng]g) are present in 
articular cartilage, principally in a latent form [62], 
and it is plausible that increased activities of 
proteolytic enzymes in the articular cartilage 
after ACL transection might activate this latent 
TGF-fl. Indeed, direct injection of active TGF-fl 
into normal murine knee joints causes an 
experimental OA with early cartilage thickening 
and osteophyte formation [62, 63]. Thus, it seems 
possible that changes in the mRNA levels of these 
small PGs seen early after joint injury, before the 
development of overt OA, may be a result of the 
action of TGF-fl. 
These changes in PG metabolism may be an 
indication of a reversion of damaged cartilage in 
early OA to a more immature form in the repair 
cartilage. The levels of biglycan are reportedly 
higher in juveniles as opposed to adults, whereas 
the levels of decorin are lower in the immature 
cartilage as compared with the mature [60]. 
Furthermore, the location of antibodies pecific to 
decorin and biglycan in late osteoarthritic arti- 
lage suggest he chondrocytes have reverted to a 
neonatal pattern of metabolism, by switching and 
reorganizing biglycan and decorin concentrations 
[17]. In the present study, all three PGs are 
significantly elevated in osteoarthrit ic cartilage as 
compared with controls, although the decorin 
mRNA levels are only modestly increased as 
compared with biglycan and fibromodulin. These 
findings would seem to agree with the hypothesis 
that during the anabolic phase of OA, cartilage is 
taking on immature properties. 
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